GSK PEG Ratio Analysis
Higher than 80% of Healthcare sector peers
Updated 1643h ago·SEC filings & market data
Key Takeaway
GSK (GSK) has a PEG Ratio of 2.52x as of June 2026.
Sector Performance
80th percentileGSK
2.52x
Sector Median
1.07x
Sector Avg
1.77x
Prior Period
2.13x(May 2026)
Deep Analysis
GSK (GSK) has a PEG Ratio of 2.52x as of June 2026.
This places GSK in the 80th percentile of the Healthcare sector, which has a median PEG Ratio of 1.07x and a sector average of 1.77x. GSK's PEG Ratio is 134.4% above the sector median, a significant divergence that warrants closer examination. In context: The PEG ratio adjusts P/E for expected growth. A PEG below 1.0 may signal undervaluation; above 2.0 may suggest the growth story is priced in.
Frequently Asked Questions
What does the PEG Ratio tell investors about GSK?
The PEG ratio adjusts P/E for expected growth. A PEG below 1.0 may signal undervaluation; above 2.0 may suggest the growth story is priced in.
How is the PEG Ratio calculated?
PEG Ratio is calculated as: P/E Ratio / EPS Growth Rate.
How does GSK's PEG Ratio compare to its sector?
GSK's PEG Ratio of 2.52x compares to a Healthcare sector median of 1.07x, placing it in the 80th percentile.
Who are GSK's closest peers by PEG Ratio?
The closest Healthcare peers by PEG Ratio include: RHHBY (0.77x), ALGN (1.38x), ZBH (0.70x), DGX (1.48x), TECH (0.62x).
Learn More About PEG Ratio
The Formula
P/E Ratio / EPS Growth Rate
Why It Matters
The PEG ratio adjusts P/E for expected growth. A PEG below 1.0 may signal undervaluation; above 2.0 may suggest the growth story is priced in.
Master GSK's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full GSK research report →GSK
2.52x
Sector Median
1.07x
Sector Avg
1.77x
How GSK's PEG Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.